David Baxley Spetzler sold $15M of CAI
President at Caris Life Sciences, Inc.. 597,212 shares at an average of $24.84, traded Sep 3, 2026, filed Sep 4, 2026.
Score components
- +20RolePresident
- +25Trade size$14.8M at market
- +10Share of holdings soldSold 39% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002071953-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | MOption exercise Common Stock | +1,000,000 | $2.44 | $2.4M | 1,530,083 | 39 d ago |
| Sep 3, 2026 | SOpen-market sale Common Stock | -393,100 | $24.76 | $9.7M | 1,136,983 | 39 d ago |
| Sep 3, 2026 | SOpen-market sale Common Stock | -84,900 | $25.32 | $2.1M | 1,052,083 | 39 d ago |
| Sep 4, 2026 | MOption exercise Common Stock | +250,000 | $2.44 | $610k | 1,302,083 | 39 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock | -119,212 | $24.76 | $3.0M | 1,182,871 | 39 d ago |
| Sep 3, 2026 | MOption exercise Stock Optionderivative | -1,000,000 | $0.00 | $0 | 250,000 | 39 d ago |
| Sep 4, 2026 | MOption exercise Stock Optionderivative | -250,000 | $0.00 | $0 | 0 | 39 d ago |
Related signals
Other insiders at Caris Life Sciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | Caris Life Sciences, Inc. | John Russel Denton See Remarks | $239k 7,500 shares | -4% | |
| 60Notable | Caris Life Sciences, Inc. | Brian J Brille See Remarks | $12M 400,000 shares | -63% | |
| 61Notable | CAIbuy Caris Life Sciences, Inc. | Jeff L Vacirca director | $501k 31,050 shares | +167% | |
| 15Weak | Caris Life Sciences, Inc. | Luke Thomas Power See Remarks | $1.7M 62,250 shares | -38% | |
| 61Notable | Caris Life Sciences, Inc. | John Russel Denton See Remarks | $101k 4,184 shares | +84% | |
| 41Moderate | Caris Life Sciences, Inc. | David Baxley Spetzler President | $9,540 400 shares | +0% | |
| 59Moderate | Caris Life Sciences, Inc. | Brian J Brille See Remarks | $630k 30,000 shares | +23% | |
| 47Moderate | Caris Life Sciences, Inc. | John Russel Denton See Remarks | $158k 7,500 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.